| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |